Cited by 793Immune cells in cancerImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

Open access

Hoechst, Bastian, Ormandy, Lars A., Ballmaier, Matthias, Lehner, Frank, Krüger, Christine, Manns, Michael P., Greten, Tim F., Korangy, Firouzeh·2008·Gastroenterology

DOI 10.1053/j.gastro.2008.03.020

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Several studies have shown that development of hepatocellular carcinoma (HCC) generates a number of immune suppressive mechanisms in these patients. Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that have been shown to inhibit T-cell responses in tumor-bearing mice, but little is known about these cells in humans owing to a lack of specific markers. In this study, we have investigated the frequency and function of a new population of MDSC denoted here as CD14(+)HLA-DR(-/low) in HCC patients. We have also identified a novel, MDSC-mediated immune regulatory pathway in these patients.Methods We have directly isolated and characterized MDSCs for phenotype and function from peripheral blood (n = 111) and tumor (n = 12) of patients with HCC.Results The frequency of CD14(+)HLA-DR(-/low) cells in peripheral blood mononuclear cells (PBMC) from HCC patients was significantly increased in comparison with healthy controls. CD14(+) HLA-DR(-/low) cells were unable to stimulate an allogeneic T-cell response, suppressed autologous T-cell proliferation, and had high arginase activity, a hallmark characteristic of MDSC. Most important, CD14(+)HLA-DR(-/low) cells from HCC patients induced a CD4(+)CD25(+)Foxp3(+) regulatory T-cell population when cocultured with autologous T cells.Conclusion CD14(+)HLA-DR(-/low) cells are a new population of MDSC increased in blood and tumor of HCC patients. We propose a new mechanism by which MDSC exert their immunosuppressive function, through the induction of CD4(+)CD25(+)Foxp3(+) regulatory T cells in cocultured CD4(+) T cells. Understanding the mechanism of action of MDSC in HCC patients is important in the design of effective immunotherapeutic protocols.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.03.020

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature reviews. Immunology · doi:10.1038/nri1806 · Cited by 2,135
Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Immune surveillance of tumors
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,518
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Писарев, В. М., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J. P., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,176
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
Gao, Q., Qiu, S., Fan, J., Zhou, J., Wang, X., Xiao, Y., Xu, Y., Li, Y., & Tang, Z. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,134
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867

Flagged first, then by citations

Show all 31 references

1 of the 31 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 790

On the armament and appearances of human myeloid-derived suppressor cells
Poschke, I. C., & Kiessling, R. W. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.06.003 · Cited by 180
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
Greten, T. F., Wang, X. W., & Korangy, F. (2015) · Gut · doi:10.1136/gutjnl-2014-307990 · Cited by 178
Self-citation
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Liu, M., Zhou, J., Liu, X., Feng, Y., Yang, W., Wu, F., Cheung, O. K.-W., Sun, H., Zeng, X., Tang, W., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317257 · Cited by 178
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis
Yi, H., Guo, C., Yu, X., Zuo, D., & Wang, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200086 · Cited by 177
Sorafenib: a clinical and pharmacologic review
Iyer, R., Fetterly, G., Lugade, A., & Thanavala, Y. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.496453 · Cited by 169
CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung Cancer
Feng, P., Lee, K., Chang, Y.-L., Chan, Y., Kuo, L.-W., Lin, T., Chung, F., Kuo, C.-S., Yu, C.-T., Lin, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0636oc · Cited by 168
Camouflage and sabotage: tumor escape from the immune system
Poschke, I. C., Mougiakakos, D., & Kiessling, R. W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1012-8 · Cited by 168
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 173
Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer
Davis, R. J., Waes, C. V., & Allen, C. T. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.05.002 · Cited by 167
Immune suppression in chronic hepatitis B infection associated liver disease: A review
Li, T.-Y., Yang, Y., Zhou, G. F., & Tu, Z. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i27.3527 · Cited by 167
Immunotherapy of hepatocellular carcinoma
Pardee, A. D., & Butterfield, L. H. (2012) · OncoImmunology · doi:10.4161/onci.1.1.18344 · Cited by 162
Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function
Hu, C., Gan, J., Zhang, R., Cheng, Y., & Huang, G. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.516450 · Cited by 161
CD14 + CD15 − HLA-DR − myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
Bernsmeier, C., Triantafyllou, E., Brenig, R., Lebosse, F. J., Singanayagam, A., Patel, V. C., Pop, O. T., Khamri, W., Nathwani, R., Tidswell, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314184 · Cited by 159
N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
Antuamwine, B. B., Bosnjakovic, R., Hofmann-Vega, F., Wang, X., Θεοδοσίου, Θ., Iliopoulos, I., & Brandau, S. (2022) · Immunological Reviews · doi:10.1111/imr.13176 · Cited by 160
Th17 cells and their associated cytokines in liver diseases
Lafdil, F., Miller, A. M., Ki, S. H., & Gao, B. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.5 · Cited by 162
Myeloid cells in hepatocellular carcinoma
Wan, S., Kuo, N., Kryczek, I., Zou, W., & Welling, T. H. (2015) · Hepatology · doi:10.1002/hep.27867 · Cited by 161
Increased Frequency of Myeloid-derived Suppressor Cells during Active Tuberculosis and after Recent Mycobacterium tuberculosis Infection Suppresses T-Cell Function
du Plessis, N., Loebenberg, L., Kriel, M., von Groote-Bidlingmaier, F., Ribechini, E., Loxton, A. G., van Helden, P. D., Lutz, M. B., & Walzl, G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0249oc · Cited by 158
IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Patil, R. S., Shah, S., Shrikhande, S. V., Goel, M., Dikshit, R. P., & Chiplunkar, S. V. (2016) · International Journal of Cancer · doi:10.1002/ijc.30134 · Cited by 162
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
O’Rourke, J. M., Sagar, V., Shah, T., & Shetty, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i39.4436 · Cited by 157
IL-6-stimulated CD11b+CD14+HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
Chen, M., Kuan, F., Yen, T., Lu, M., Lin, P.-Y., Chung, Y.-H., Chen, W., & Lee, K. (2014) · Oncotarget · doi:10.18632/oncotarget.2368 · Cited by 158
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
Yu, S. J., Ma, C., Heinrich, B., Brown, Z. J., Sandhu, M., Zhang, Q., Fu, Q., Agdashian, D., Rosato, U., Korangy, F., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.040 · Cited by 156
Self-citation
The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
Mengos, A. E., Gastineau, D. A., & Gustafson, M. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01147 · Cited by 162
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Kaps, L., & Schuppan, D. (2020) · Cells · doi:10.3390/cells9092027 · Cited by 160
Hepatic Stellate Cells and Hepatocarcinogenesis
Barry, A. E., Baldeosingh, R., Lamm, R. J., Patel, K., Zhang, K., Dominguez, D. A., Kirton, K. J., Shah, A. P., & Dang, H. T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00709 · Cited by 159
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Stewart, T. J., & Smyth, M. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9280-5 · Cited by 152
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
Ji, J., Eggert, T., Budhu, A., Forgues, M., Takai, A., Dang, H. T., Ye, Q., Lee, J., Kim, J. H., Greten, T. F., et al. (2015) · Hepatology · doi:10.1002/hep.27822 · Cited by 155
Self-citation
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
Vollbrecht, T., Stirner, R., Tufman, A., Roider, J., Huber, R. M., Bogner, J. R., Lechner, A., Bourquin, C., & Draenert, R. (2012) · AIDS · doi:10.1097/qad.0b013e328354b43f · Cited by 150
Development and Function of Myeloid-Derived Suppressor Cells Generated From Mouse Embryonic and Hematopoietic Stem Cells
Zhou, Z., French, D. L., Ma, G., Eisenstein, S. G., Chen, Y., Divino, C. M., Keller, G. M., Chen, S., & Pan, P. (2010) · Stem Cells · doi:10.1002/stem.301 · Cited by 151
Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study
Hazeldine, J., Naumann, D. N., Toman, E., Davies, D. J., Bishop, J. R. B., Su, Z., Hampson, P., Dinsdale, R. J., Crombie, N. C., Duggal, N. A., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002338 · Cited by 149
Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer
Aerts, J. G. J. V., & Hegmans, J. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3932 · Cited by 148
Myeloid-derived suppressor cells: The green light for myeloma immune escape
Malek, E., Lima, M. J. G. D., Letterio, J. J., Kim, B., Finke, J. H., Driscoll, J. J., & Giralt, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.04.002 · Cited by 147
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Hao, X., Sun, G., Zhang, Y., Kong, X., Rong, D., Song, J., Tang, W., & Wang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775462 · Cited by 147
Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
Najjar, Y. G., & Finke, J. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00049 · Cited by 146
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
Yahoo, N., Dudek, M., Knolle, P. A., & Heikenwälder, M. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 147
Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
Jordan, K. R., Amaria, R. N., Ramirez, O., Callihan, E., Gao, D., Borakove, M., Manthey, E., Borges, V. F., & McCarter, M. D. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1475-x · Cited by 144
PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K. O., Moysich, K. B., & Kaliński, P. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.695417 · Cited by 146
Monocytic Myeloid-Derived Suppressor Cells Accumulate in Renal Transplant Patients and Mediate CD4+Foxp3+ Treg Expansion
Luan, Y., Mosheir, E., Menon, M. C., Wilson, D., Woytovich, C., Ochando, J., & Murphy, B. T. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12461 · Cited by 148
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
Kole, C., Charalampakis, N., Tsakatikas, S. A., Vailas, M. G., Moris, D., Gkotsis, E., Kykalos, S., Karamouzis, M. V., & Schizas, D. (2020) · Cancers · doi:10.3390/cancers12102859 · Cited by 144
Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
Höchst, B., Schildberg, F. A., Sauerborn, P., Gäbel, Y. A., Gevensleben, H., Goltz, D., Heukamp, L. C., Türler, A., Ballmaier, M., Gieseke, F., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.033 · Cited by 146
Self-citation
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
Dorhoi, A., & du Plessis, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01895 · Cited by 143
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development
Brown, Z. J., Fu, Q., Ma, C., Kruhlak, M. J., Zhang, H., Luo, J., Heinrich, B., Yu, S. J., Zhang, Q., Wilson, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0687-6 · Cited by 144
Self-citation
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
de Coaña, Y. P., Wolodarski, M., Poschke, I., Yoshimoto, Y., Yang, Y., Nyström, M., Edbäck, U., Brage, S. E., Lundqvist, A., Masucci, G. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15368 · Cited by 139
Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
Yaseen, M. M., Abuharfeil, N. M., Darmani, H., & Daoud, A. K. (2020) · Open Biology · doi:10.1098/rsob.200111 · Cited by 138
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
Bruger, A. M., Dorhoi, A., Esendağlı, G., Barczyk‐Kahlert, K., van der Bruggen, P., Lipoldová, M., Perečko, T., Santibanez, J. F., Saraiva, M., Ginderachter, J. A. V., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2170-8 · Cited by 137
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
Piersma, S. J. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0066-7 · Cited by 140
MDSC in autoimmunity
Cripps, J. G., & Gorham, J. D. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.026 · Cited by 135
STAT3: A Target to Enhance Antitumor Immune Response
Lee, H., Pal, S. K., Reckamp, K. L., Figlin, R. A., & Yu, H. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_51 · Cited by 138
Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation
Lin, Y., Yang, X., Liu, W., Li, B., Yin, W., Shi, Y., & He, R. (2017) · Oncogene · doi:10.1038/onc.2016.516 · Cited by 136
Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections
Stauffer, J. K., Scarzello, A. J., Jiang, Q., & Wiltrout, R. H. (2012) · Hepatology · doi:10.1002/hep.25674 · Cited by 135
Myeloid-Derived Suppressor Cells in Bacterial Infections
Ost, M., Singh, A., Peschel, A., Mehling, R., Rieber, N. P., & Hartl, D. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00037 · Cited by 139
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
Kittang, A. O., Kordasti, S. Y., Sand, K. E., Costantini, B., Kramer, A. M., Abellan, P. P., Seidl, T., Rye, K. P., Hagen, K. M., Kulasekararaj, A. G., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062208 · Cited by 132
Systemic Reprogramming of Monocytes in Cancer
Kiss, M., Caro, A. A., Raes, G., & Laoui, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01399 · Cited by 133
Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Nishida, N., & Kudo, M. (2016) · Oncology · doi:10.1159/000451015 · Cited by 132
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 138
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
Poschke, I. C., Mao, Y., Adamson, L., Salazar‐Onfray, F., Masucci, G. V., & Kiessling, R. W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1143-y · Cited by 137
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014) · Journal of Immunology Research · doi:10.1155/2014/879897 · Cited by 130
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Christiansson, L. H., Söderlund, S., Svensson, E., Mustjoki, S. M., Bengtsson, M., Simonsson, B., Olsson‐Strömberg, U., & Loskog, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055818 · Cited by 129
Increased regulatory B cells are involved in immune evasion in patients with gastric cancer
Murakami, Y., Saito, H., Shimizu, S., Kono, Y., Shishido, Y., Miyatani, K., Matsunaga, T., Fukumoto, Y., Ashida, K., Sakabe, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49581-4 · Cited by 133
Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
Greten, T. F., Ormandy, L. A., Fikuart, A., Höchst, B., Henschen, S., Hörning, M., Manns, M. P., & Korangy, F. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181bb499f · Cited by 127
Self-citation
Potential of immunotherapy for hepatocellular carcinoma
Breous, E., & Thimme, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.013 · Cited by 127
Hepatic Stellate Cells Regulate Immune Response by Way of Induction of Myeloid Suppressor Cells in Mice Δσ
Chou, H.-S., Hsieh, C., Yang, H.-R., Wang, L., Arakawa, Y., Brown, K., Wu, Q., Lin, F., Peters, M. G., Fung, J. J., et al. (2011) · Hepatology · doi:10.1002/hep.24162 · Cited by 126
Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
Cao, M., Xu, Y., Youn, J., Cabrera, R., Zhang, X., Gabrilovich, D. I., Nelson, D. R., & Liu, C. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.205 · Cited by 129
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
Schilling, B., Sucker, A., Griewank, K., Zhao, F., Weide, B., Görgens, A., Giebel, B., Schadendorf, D., & Paschen, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28168 · Cited by 124
Myeloid‐derived suppressor cells in parasitic infections
Ginderachter, J. A. V., Beschin, A., BAETSELIER, P. D., & Raes, G. (2010) · European Journal of Immunology · doi:10.1002/eji.201040911 · Cited by 124
Immune cell therapy for hepatocellular carcinoma
Mizukoshi, E., & Kaneko, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0742-5 · Cited by 126
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion
Zoso, A., Mazza, E. M. C., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201444522 · Cited by 123
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Harding, J. J., Dika, I. E., & Abou‐Alfa, G. K. (2015) · Cancer · doi:10.1002/cncr.29769 · Cited by 125
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
Pawelec, G., Verschoor, C. P., & Ostrand‐Rosenberg, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01099 · Cited by 126
Immunobiology of cholangiocarcinoma
Loeuillard, E. J., Conboy, C. B., Gores, G. J., & Ilyas, S. I. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.06.003 · Cited by 123
Immunology of hepatocellular carcinoma
Sachdeva, M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2080 · Cited by 122
The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver
Wilkinson, A. L., Qurashi, M., & Shetty, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00990 · Cited by 121
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy
Mundy-Bosse, B. L., Young, G. S., Bauer, T. M., Binkley, E. M., Bloomston, M., Bill, M. A., Bekaii‐Saab, T., Carson, W. E., & Lesinski, G. B. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1029-z · Cited by 121
A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients
Vetsika, E., Koinis, F., Gioulbasani, M., Aggouraki, D., Koutoulaki, A., Skalidaki, E., Mavroudis, D., Georgoulias, V., & Kotsakis, A. P. (2014) · Journal of Immunology Research · doi:10.1155/2014/659294 · Cited by 127
Myeloid-derived suppressor cells in hematological malignancies: friends or foes
Lv, M., Wang, K., & Huang, X. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0797-3 · Cited by 121
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
Mougiakakos, D., Jitschin, R., von Bahr, L., Poschke, I. C., Gary, R., Sundberg, B., Gerbitz, A., Ljungman, P. T., & Blanc, K. L. (2012) · Leukemia · doi:10.1038/leu.2012.215 · Cited by 120
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
Messmer, M. N., Netherby, C. S., Banik, D., & Abrams, S. I. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1639-3 · Cited by 121
Myeloid‐derived suppressor cells: the dark knight or the joker in viral infections?
Yergin, C. G., Narayanan, S., & Hahn, Y. S. (2013) · Immunological Reviews · doi:10.1111/imr.12084 · Cited by 120
Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches
Wang, Y., Zhong, X., He, X., Hu, Z., Huang, H., Chen, J., Chen, K., Zhao, S., Wei, P., & Li, D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02729-7 · Cited by 131
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
Brown, Z. J., Yu, S. J., Heinrich, B., Ma, C., Fu, Q., Sandhu, M., Agdashian, D., Zhang, Q., Korangy, F., & Greten, T. F. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2190-4 · Cited by 119
Self-citation
Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
Lurje, I., Hammerich, L., & Tacke, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197378 · Cited by 118
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yin, Y., Feng, W., Chen, J., Chen, X., Wang, G., Wang, S., Xu, X., Nie, Y., Fan, D., Wu, K., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00539-x · Cited by 122
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Tada, F., Abe, M., Hirooka, M., Ikeda, Y., Hiasa, Y., Lee, Y., Jung, N.-C., LEE, W.-B., Lee, H., Bae, Y., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1626 · Cited by 117
Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
Chesney, J. A., Mitchell, R. A., & Yaddanapudi, K. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5vmr1116-458rrr · Cited by 120
Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
Gielen, P. R., Schulte, B. M., Kers‐Rebel, E. D., Verrijp, K. C. N., Petersen-Baltussen, H. M. J. M., ter Laan, M., Wesseling, P., & Adema, G. J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000183 · Cited by 117
Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling
Obermajer, N., Wong, J. L., Edwards, R. P., Chen, K., Scott, M. J., Khader, S. A., Kolls, J. K., Odunsi, K. O., Billiar, T. R., & Kaliński, P. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121277 · Cited by 120
Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
Yang, G., Shen, W., Zhang, Y., Liu, M., Zhang, L., Liu, Q., Lu, H. H., & Bo, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16386 · Cited by 118
Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Sène, D., Levasseur, F., Abel, M., Lambert, M., Camous, X., Hernandez, C., Pène, V., Rosenberg, A. R., Jouvin-Marche, E., Marche, P. N., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001184 · Cited by 113
T regulatory cells in cancer: recent advances and therapeutic potential
Elkord, E., Alcantar-Orozco, E., Dovedi, S. J., Tran, D. Q., Hawkins, R. E., & Gilham, D. E. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.529126 · Cited by 113
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
Favaloro, J., Liyadipitiya, T., Brown, R. D., Yang, S., Suen, H., Woodland, N., Nassif, N. T., Hart, D. N. J., Fromm, P. D., Weatherburn, C., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.904511 · Cited by 113
Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients
Wu, L., Deng, Z., Peng, Y., Han, L., Liu, J., Wang, L., Li, B., Zhao, J., Jiao, S., & Wei, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20164 · Cited by 114
Tumor metastasis: Mechanistic insights and therapeutic interventions
Liu, M., Yang, J., Xu, B.-S., & Zhang, X. (2021) · MedComm · doi:10.1002/mco2.100 · Cited by 124
Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
Zhao, W., Zhang, L., Xu, Y., Zhang, Z., Ren, G., Tang, K., Kuang, P., Zhao, B., Yin, Z., & Wang, X. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2013.139 · Cited by 111
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Foerster, F., Hess, M., Gerhold‐Ay, A., Marquardt, J. U., Becker, D., Galle, P. R., Schuppan, D., Binder, H., & Bockamp, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21937-2 · Cited by 113
Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
Brown, Z. J., Greten, T. F., & Heinrich, B. (2019) · Hepatology · doi:10.1002/hep.30633 · Cited by 110
Self-citation
Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review
Li, B., Yan, C., Zhu, J., Chen, X., Fu, Q., Zhang, H., Tong, Z., Liu, L., Zheng, Y., Zhao, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01037 · Cited by 111
Myeloid-Derived Suppressor Cells in Solid Tumors
Ma, T., Renz, B. W., Ilmer, M., Koch, D. T., Yang, Y., Werner, J., & Bazhin, A. V. (2022) · Cells · doi:10.3390/cells11020310 · Cited by 110
Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines
Chen, H., Chen, H.-Y., Wang, L., Wang, F.-H., Fang, L.-W., Lai, H.-Y., Chen, H.-H., Lu, J., Hung, M., Cheng, Y., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202775 · Cited by 110
Immunosuppressive activity of CD 14+ HLA ‐ DR − cells in squamous cell carcinoma of the head and neck
Chikamatsu, K., Sakakura, K., Toyoda, M., Takahashi, K., Yamamoto, T., & Masuyama, K. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02248.x · Cited by 108
Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases
Liepelt, A., & Tacke, F. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2016 · Cited by 108

Authors: Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F.
Affiliations: Medizinische Hochschule Hannover (DE)
Corresponding author: Korangy, Firouzeh
ORCID: Ballmaier, Matthias
Lehner, Frank
Manns, Michael P.
Greten, Tim F.
Korangy, Firouzeh
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2008-07
Volume: 135
Issue: 1
Pages: 234-243
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2008.03.020
OpenAlex: W2059688175
Cited by: 793
References: 31
Citations by year: 2026: 18 · 2025: 20 · 2024: 25 · 2023: 34 · 2022: 50 · 2021: 46 · 2020: 53 · 2019: 40 · 2018: 39 · 2017: 60 · 2016: 54 · 2015: 65 · 2014: 55 · 2013: 65 · 2012: 59
FWCI: 15.02
Type: journal article
Language: en
Update notices: erratum (2011-08-01)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft (SFB-738)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: myeloid-derived suppressor cells, hepatocellular carcinoma, regulatory T cells, immunosuppression, arginase activity, CD4+CD25+Foxp3+ T cells, tumor immune microenvironment, T cell proliferation inhibition, cancer immunotherapy
MeSH terms: Aged, Arginase, Cell Communication, Cell Division, Cells, Cultured, Female, Flow Cytometry, Carcinoma, Hepatocellular, HLA-DR Antigens, Humans, Immune Tolerance, Liver Neoplasms, Male, Middle Aged, Biomarkers, CD4-Positive T-Lymphocytes, CD4 Antigens, Immunophenotyping, Interleukin-10, Lipopolysaccharide Receptors, Myeloid Cells, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks